Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical Performance
- Conditions
- Sacrocolpopexy
- Registration Number
- NCT07031050
- Lead Sponsor
- Distalmotion SA
- Brief Summary
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted sacrocolpopexy or sacrocervicopexy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Aged > 18 years
- Women with symptomatic stage I or greater pelvic organ prolapse (POP-Q)
- Patient agrees to perform the 6-week follow-up assessment as per Standard of Care
- Any planned non-urogynaecological concomitant procedures
- History of previous POP surgery, with the exception of transvaginal approaches without mesh implantation
- Previous surgery and/or radiation for urologic, gastrointestinal or gynecologic cancer
- History of Crohn's disease
- Chronic colitis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary safety outcome up to 42 days after surgery Occurrence of Clavien-Dindo grades III-V adverse events
Primary efficacy outcome Intraoperative Successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
Charité - Universitätsmedizin Berlin
🇩🇪Berlin, Germany
Universitätsklinikum Bonn
🇩🇪Bonn, Germany
Krankenhaus St. Elisabeth
🇩🇪Damme, Germany
Universitätsmedizin Essen
🇩🇪Essen, Germany
Inselspital Bern
🇨🇭Bern, Switzerland
Spitäler FMI AG
🇨🇭Interlaken, Switzerland
Charité - Universitätsmedizin Berlin🇩🇪Berlin, GermanyJörg Neymeyer, MDContact+4930450515272joerg.neymeyer@charite.de